These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform. Rossen BR Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746 [TBL] [Abstract][Full Text] [Related]
3. Clinical trials integrity: a CRO perspective. Beach JE Account Res; 2001; 8(3):245-60. PubMed ID: 12481762 [TBL] [Abstract][Full Text] [Related]
4. Managing oncology research protocols. Lunik MC Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201 [TBL] [Abstract][Full Text] [Related]
5. Pharmacies' noncompliance with 2009 Joint Commission hospital accreditation requirements. Rich DS Am J Health Syst Pharm; 2010 Jan; 67(2):144-7. PubMed ID: 20065269 [No Abstract] [Full Text] [Related]
6. Operation of a radiopharmacy for a clinical trial. Norenberg JP; Petry NA; Schwarz S Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594 [TBL] [Abstract][Full Text] [Related]
7. Controlling investigational drug use in community hospitals. Chase PA Am J Hosp Pharm; 1991 Jan; 48(1):61-2. PubMed ID: 2000874 [No Abstract] [Full Text] [Related]
8. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
9. ASHP guidelines for the use of investigational drugs in institutions. Am J Hosp Pharm; 1983 Mar; 40(3):449-51. PubMed ID: 6846357 [No Abstract] [Full Text] [Related]
10. Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing Concerns. Goldman SA Drug Saf; 2016 Oct; 39(10):895-901. PubMed ID: 27473417 [TBL] [Abstract][Full Text] [Related]
11. A perspective on investigational drug management. Hill DP; Browning DA Top Hosp Pharm Manage; 1993 Apr; 13(1):29-36. PubMed ID: 10128790 [TBL] [Abstract][Full Text] [Related]
12. Computer-assisted investigational drug information and testing mechanism for nurses. Wermeling DP; Nowak-Rapp M; Sitzlar S Hosp Pharm; 1994 Aug; 29(8):745-6, 748-50. PubMed ID: 10135743 [TBL] [Abstract][Full Text] [Related]
13. GCP data quality for early clinical development. Rock EP; Molloy VJ; Humphrey JS Clin Cancer Res; 2010 Mar; 16(6):1756-63. PubMed ID: 20215550 [TBL] [Abstract][Full Text] [Related]
14. [Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"]. Hvidberg EF Ugeskr Laeger; 1994 Feb; 156(6):789-93. PubMed ID: 8016980 [TBL] [Abstract][Full Text] [Related]
15. Current issues surrounding women and minorities in drug trials. Wermeling DP; Selwitz AS Ann Pharmacother; 1993; 27(7-8):904-11. PubMed ID: 8364277 [TBL] [Abstract][Full Text] [Related]
16. International regulatory aspects of clinical periodontal research. Cooley WE; Castellion AW Ann Periodontol; 1997 Mar; 2(1):18-30. PubMed ID: 9151540 [TBL] [Abstract][Full Text] [Related]
17. A national survey on hospital formulary management processes. Anagnostis E; Wordell C; Guharoy R; Beckett R; Price V J Pharm Pract; 2011 Aug; 24(4):409-16. PubMed ID: 21768310 [TBL] [Abstract][Full Text] [Related]
18. State payer mandates to cover care in US oncology trials: do science and ethics matter? Taylor PL J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514 [TBL] [Abstract][Full Text] [Related]
19. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096 [TBL] [Abstract][Full Text] [Related]